Alcohol drinking and liver cancer risk: An evaluation based on a systematic review of epidemiologic evidence among the Japanese population

Japanese Journal of Clinical Oncology

Volumn 38, Issue 12, 2008, Pages 816-838

  Tanaka, Keitaro ^a   Tsuji, Ichiro ^b   Wakai, Kenji ^c   Nagata, Chisato ^d   Mizoue, Tetsuya ^e   Inoue, Manami ^f   Tsugane, Shoichiro ^f  

^a SAGA UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^f NATIONAL CANCER CENTER   (Japan)

Author keywords

Alcohol; Epidemiology; Japanese; Liver cancer; Systematic review

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 2; INTERFERON;

ACCESS TO INFORMATION; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RESEARCH; CANCER RISK; CANCER SUSCEPTIBILITY; CHRONIC LIVER DISEASE; COHORT ANALYSIS; DATA BASE; DISEASE ASSOCIATION; DRINKING BEHAVIOR; ENDOSCOPY; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; FOLLOW UP; GENETIC RISK; HEPATITIS C; HETEROZYGOTE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; JAPANESE; LABORATORY TEST; LIVER CANCER; MEDICAL INFORMATION; MEDICAL RESEARCH; MEDLINE; POPULATION BASED CASE CONTROL STUDY; POPULATION RESEARCH; PREVALENCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW;

ALCOHOL DRINKING; CASE-CONTROL STUDIES; COHORT STUDIES; HUMANS; JAPAN; LIFE STYLE; LIVER NEOPLASMS; RISK ASSESSMENT; RISK FACTORS;

EID: 57249107930     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyn108     Document Type: Review

References (61)

1. Lieber CS. Alcohol and the liver: 1994 update. Gastroenterology 1994;106:1085-105.
2. Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: Incidence and risk factors. Gastroenterology 2004;127: S35-50.
3. International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 96. Consumption of Alcoholic Beverages and Ethyl Carbamate (Urethane). Lyon, France: IARC (in press).
4. World Cancer Research Fund, American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: AICR 2007.
5. Gann Monograph on Cancer Research No. 51. Cancer Mortality and Morbidity Statistics: Japan and the World-2004. Tokyo, Japan: Scientific Societies Press 2004.
6. Ikai I, Arii S, Okazaki M, Okita K, Omata M, Kojiro M, et al. Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Hepatol Res 2007;37:676-91.
7. Tanaka K, Ikematsu H, Hirohata T, Kashiwagi S. Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: Possible role of type 1b (II) infection. J Natl Cancer Inst 1996;88:742-6.
8. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003;362:1907-17.
9. Goedde HW, Agarwal DP, Fritze G, Meier-Tackmann D, Singh S, Beckmann G, et al. Distribution of ADH2 and ALDH2 genotypes in different populations. Hum Genet 1992;88:344-6.
10. International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 71. Re-evaluation of Some Organic Chemicals, Hydrazine and Hydrogen Peroxide. Lyon, France: IARC 1999.
11. Inoue M, Tsuji I, Wakai K, Nagata C, Mizoue T, Tanaka K, et al. Evaluation based on systematic review of epidemiological evidence among Japanese populations: Tobacco smoking and total cancer risk. Jpn J Clin Oncol 2005;35:404-11.
12. World Health Organization. WHO Technical Reports Series 916. Diet, Nutrition and the Prevention of Chronic Diseases: Report of a Joint WHO/ FAO Expert Consultation. Geneva, WHO 2003.
13. Kono S, Ikeda M, Tokudome S, Nishizumi M, Kuratsune M. Cigarette smoking, alcohol and cancer mortality: A cohort study of male Japanese physicians. Jpn J Cancer Res 1987;78:1323-8.
14. Hirayama T. A large-scale cohort study on risk factors for primary liver cancer, with special reference to the role of cigarette smoking. Cancer Chemother Pharmacol 1989;23(Suppl.):S114-7.
15. Inaba Y, Kikuchi S, Namihisa T, Ichikawa S. The effect of smoking and drinking habit on the process from liver cirrhosis to liver cancer. Gan No Rinsho 1990;36:299-304 (in Japanese).
16. Shibata A, Fukuda K, Toshima H, Tashiro H, Hirohata T. The role of cigarette smoking and drinking in the development of liver cancer: 28 years of observations on male cohort members in a farming and fishing area. Cancer Detect Prev 1990;14:617-23.
17. Kato I, Tominaga S, Ikari A. The risk and predictive factors for developing liver cancer among patients with decompensated liver cirrhosis. Jpn J Clin Oncol 1992;22:278-85.
18. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993;328:1797-801.
19. Goodman MT, Moriwaki H, Vaeth M, Akiba S, Hayabuchi H, Mabuchi K. Prospective cohort study of risk factors for primary liver cancer in Hiroshima and Nagasaki, Japan. Epidemiology 1995;6:36-41.
20. Chiba T, Matsuzaki Y, Abei M, Shoda J, Tanaka N, Osuga T, et al. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma. Am J Gastroenterol 1996;91:1195-203.
21. Ikeda K, Saitoh S, Suzuki Y, Kobayashi M, Tsubota A, Koida I, et al. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: A prospective observation of 2215 patients. J Hepatol 1998;28:930-8.
22. Tanaka K, Sakai H, Hashizume M, Hirohata T. A long-term follow-up study on risk factors for hepatocellular carcinoma among Japanese patients with liver cirrhosis. Jpn J Cancer Res 1998;89:1241-50.
23. Matsushita E, Kaneko S, Kobayashi K. Evaluation of background factors related to carcinogenesis in cirrhosis. Proceedings of 20th Inuyama Symposium. Tokyo: Chugai-igakusha 1998,159-64 (in Japanese).
24. Aizawa Y, Shibamoto Y, Takagi I, Zeniya M, Toda G. Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. A long term follow-up study after histologic diagnosis. Cancer 2000;89:53-9.
25. Mori M, Hara M, Wada I, Hara T, Yamamoto K, Honda M, et al. Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. Am J Epidemiol 2000;151:131-9.
26. Noda T, Imamichi H, Tanaka H, Kawata A, Hirano K, Ando T, et al. Cause-specific mortality risk among male alcoholics residing in the Osaka metropolitan area. Psychiatry Clin Neurosci 2001;55: 465-72.
27. Hamada H, Yatsuhashi H, Yano K, Daikoku M, Arisawa K, Inoue O, et al. Impact of aging on the development of hepatocellular carcinoma in patients with posttransfusion chronic hepatitis C. Cancer 2002;95: 331-9.
28. Takimoto M, Ohkoshi S, Ichida T, Takeda Y, Nomoto M, Asakura H, et al. Interferon inhibits progression of liver fibrosis and reduces the risk of hepatocarcinogenesis in patients with chronic hepatitis C: A retrospective multicenter analysis of 652 patients. Dig Dis Sci 2002;47:170-6.
29. Uetake S, Yamauchi M, Itoh S, Kawashima O, Takeda K, Ohata M. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: Clinical significance of prior hepatitis B virus infection. Alcohol Clin Exp Res 2003;27:47S-51S.
30. Iwasaki Y, Takaguchi K, Ikeda H, Makino Y, Araki Y, Ando M, et al. Risk factors for hepatocellular carcinoma in hepatitis C patients with sustained virologic response to interferon therapy. Liver Int 2004;24:603-10.
31. Ogimoto I, Shibata A, Kurozawa Y, Nose T, Yoshimura T, Suzuki H, et al. Risk of death due to hepatocellular carcinoma among drinkers and ex-drinkers. Univariate analysis of JACC study data. Kurume Med J 2004;51:59-70.
32. Nakaya N, Tsubono Y, Kuriyama S, Hozawa A, Shimazu T, Kurashima K, et al. Alcohol consumption and the risk of cancer in Japanese men: The Miyagi cohort study. Eur J Cancer Prev 2005;14:169-74.
33. Ikeda K, Marusawa H, Osaki Y, Nakamura T, Kitajima N, Yamashita Y, et al. Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: A prospective study. Ann Intern Med 2007;146:649-56.
34. Ohki T, Tateishi R, Sato T, Masuzaki R, Imamura J, Goto T, et al. Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients. Clin Gastroenterol Hepatol 2008;6:459-64.
35. Inaba Y, Maruchi N, Matsuda M, Yoshihara N, Yamamoto S. A case-control study on liver cancer with special emphasis on the possible aetiological role of schistosomiasis. Int J Epidemiol 1984;13:408-12.
36. Oshima A, Tsukuma H, Hiyama T, Fujimoto I, Yamano H, Tanaka M. Follow-up study of HBs Ag-positive blood donors with special reference to effect of drinking and smoking on development of liver cancer. Int J Cancer 1984;34:775-9.
37. Hiraga M, Araki S, Murata K, Yokoyama K, Terao H. Assessment of the interaction of hepatitis B antigen and alcohol in primary hepatocellular carcinoma: A case-control study. Jpn J Public Health 1986;33:636-9 (in Japanese).
38. Kiyosawa K, Imai H, Sodeyama T, Franca ST, Yousuf M, Furuta S, et al. Comparison of anamnestic history, alcohol intake and smoking, nutritional status, and liver dysfunction between thorotrast patients who developed primary liver cancer and those who did not. Environ Res 1989;49:166-72.
39. Kobayashi K, Unoura M, Tanaka N, Hattori N. A comparison between hepatocellular carcinoma-developing and non-carcinoma-developing patients with cirrhosis over a long follow-up period. Hepatogastroenterology 1990;37:445-8.
40. Tsukuma H, Hiyama T, Oshima A, Sobue T, Fujimoto I, Kasugai H, et al. A case-control study of hepatocellular carcinoma in Osaka, Japan. Int J Cancer 1990;45:231-6.
41. Tanaka K, Hirohata T, Takeshita S, Hirohata I, Koga S, Sugimachi K, et al. Hepatitis B virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: A case-control study in Fukuoka, Japan. Int J Cancer 1992;51:509-14.
42. Haratake J, Kasai T, Takeda S. An epidemiologic comparative study of hepatocellular carcinoma caused by various etiologic factors. Gan No Rinsho 1992;38:297-301 (in Japanese).
43. Fukuda K, Shibata A, Hirohata I, Tanikawa K, Yamaguchi G, Ishii M. A hospital-based case-control study on hepatocellular carcinoma in Fukuoka and Saga Prefectures, northern Kyushu, Japan. Jpn J Cancer Res 1993;84:708-14.
44. Yamaguchi G. Hepatocellular carcinoma and its risk factors-their annual changes and effects on the age at onset. Kurume Med J 1993;40:33-40.
45. Une H, Osajima K, Momose Y, Esaki H. A case-control study on liver cancer in the Chikuho area, Fukuoka prefecture. Minzoku Eisei 1993;59:241-7.
46. Tanaka H, Hiyama T, Tsukuma H, Imaoka S, Morisada K, Iwanaga T. Association of HBV, HCV, drinking and smoking with the development of hepatocellular carcinoma: A case-control study using hospitalized patients. Shokaki Gan 1995;5:117-22 (in Japanese).
47. Chiba T, Matsuzaki Y, Abei M, Shoda J, Aikawa T, Tanaka N, et al. Multivariate analysis of risk factors for hepatocellular carcinoma in patients with hepatitis C virus-related liver cirrhosis. J Gastroenterol 1996;31:552-8.
48. Murata M, Takayama K, Choi BC, Pak AW. A nested case-control study on alcohol drinking, tobacco smoking, and cancer. Cancer Detect Prev 1996;20:557-65.
49. Shibata A, Fukuda K, Nishiyori A, Ogimoto I, Sakata R, Tanikawa K. A case-control study on male hepatocellular carcinoma based on hospital and community controls. J Epidemiol 1998;8:1-5.
50. Mukaiya M, Nishi M, Miyake H, Hirata K. Chronic liver diseases for the risk of hepatocellular carcinoma: A case-control study in Japan. Etiologic association of alcohol consumption, cigarette smoking and the development of chronic liver diseases. Hepatogastroenterology 1998;45:2328-32.
51. Takeshita T, Yang X, Inoue Y, Sato S, Morimoto K. Relationship between alcohol drinking, ADH2 and ALDH2 genotypes, and risk for hepatocellular carcinoma in Japanese. Cancer Lett 2000;149: 69-76.
52. Koide T, Ohno T, Huang XE, Iijima Y, Sugihara K, Mizokami M, et al. HBV/ HCV infection, alcohol, tobacco and genetic polymorphisms for hepatocellular carcinoma in Nagoya, Japan. Asian Pac J Cancer Prev 2000;1:237-43.
53. Iida F, Yamagata Z, Iida R, Hosoda K, Okada S, Matsuda M, et al. Hepatocellular carcinoma in Yamanashi prefecture - a trial of case-control study (third report). Yamanashi Igaku 2002;30:1-7 (in Japanese).
54. Matsuo M. Association between diabetes mellitus and hepatocellular carcinoma: Results of a hospital- and community-based case-control study. Kurume Med J 2003;50:91-8.
55. Munaka M, Kohshi K, Kawamoto T, Takasawa S, Nagata N, Itoh H, et al. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma. J Cancer Res Clin Oncol 2003;129:355-60.
56. Sakamoto T, Hara M, Higaki Y, Ichiba M, Horita M, Mizuta T, et al. Influence of alcohol consumption and gene polymorphisms of ADH2 and ALDH2 on hepatocellular carcinoma in a Japanese population. Int J Cancer 2006;118:1501-7.
57. Fukushima W, Tanaka T, Ohfuji S, Habu D, Tamori A, Kawada N, et al. Does alcohol increase the risk of hepatocellular carcinoma among patients with hepatitis C virus infection? Hepatol Res 2006;34: 141-9.
58. Ohishi W, Fujiwara S, Cologne JB, Suzuki G, Akahoshi M, Nishi N, et al. Risk factors for hepatocellular carcinoma in a Japanese population: A nested case-control study. Cancer Epidemiol Biomarkers Prev 2008;17:846-54.
59. Vento S, Cainelli F. Does hepatitis C virus cause severe liver disease only in people who drink alcohol? Lancet Infect Dis 2002;2303-9.
60. Koike K, Tsutsumi T, Miyoshi H, Shinzawa S, Shintani Y, Fujie H, et al. Molecular basis for the synergy between alcohol and hepatitis C virus in hepatocarcinogenesis. J Gastroenterol Hepatol 2008;23(Suppl. 1):S87-91.
61. Kato S, Tajiri T, Matsukura N, Matsuda N, Taniai N, Mamada H, et al. Genetic polymorphisms of aldehyde dehydrogenase 2, cytochrome p450 2E1 for liver cancer risk in HCV antibody-positive japanese patients and the variations of CYP2E1 mRNA expression levels in the liver due to its polymorphism. Scand J Gastroenterol 2003;38: 886-93.